Skip to content

Clinical trials

Phase 1 Esophageal Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20132
20171
20182
20191
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADC Therapeutics S.A.1
BeiGene1
Eli Lilly and Company1
Merck KGaA, Darmstadt, Germany1
Novartis Pharmaceuticals1
Pfizer1
Seagen Inc.1
Seagen, a wholly owned subsidiary of Pfizer1
Shionogi1
The Christie NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms12
Carcinoma, Non-Small-Cell Lung7
Ovarian Neoplasms6
Urinary Bladder Neoplasms6
Stomach Neoplasms5
Head and Neck Neoplasms4
Esophageal Squamous Cell Carcinoma3
Pancreatic Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.